Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $330092.0.

  • Krystal Biotech's Treasury Shares rose 663.51% to $330092.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $330092.0, marking a year-over-year increase of 663.51%. This contributed to the annual value of $308096.0 for FY2024, which is 9148.29% up from last year.
  • Latest data reveals that Krystal Biotech reported Treasury Shares of $330092.0 as of Q3 2025, which was up 663.51% from $338878.0 recorded in Q2 2025.
  • Krystal Biotech's 5-year Treasury Shares high stood at $348757.0 for Q1 2025, and its period low was $66600.0 during Q2 2022.
  • Moreover, its 5-year median value for Treasury Shares was $162200.0 (2023), whereas its average is $191258.4.
  • In the last 5 years, Krystal Biotech's Treasury Shares crashed by 3259.11% in 2022 and then soared by 15930.93% in 2023.
  • Krystal Biotech's Treasury Shares (Quarter) stood at $98800.0 in 2021, then plummeted by 32.59% to $66600.0 in 2022, then surged by 141.59% to $160900.0 in 2023, then surged by 91.48% to $308096.0 in 2024, then increased by 7.14% to $330092.0 in 2025.
  • Its Treasury Shares was $330092.0 in Q3 2025, compared to $338878.0 in Q2 2025 and $348757.0 in Q1 2025.